(6R,7R)-7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid(CAS: 65052-63-3)

This compound must adhere to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous communication. In Europe, it is also subject to REACH regulations. It may require FDA/EPA approval for pharmaceutical or environmental purposes, respectively. Specific handling, storage, and disposal requirements must be followed based on potential hazards and regulatory bodies involved.

Alternative reagents such as similar amino acid derivatives or thiazole-containing compounds can be used. Isomers of this compound or analogs with similar functional groups might also be considered. The choice depends on the desired properties and the specific application in synthesis.

Research trends suggest increasing interest in this compound for its antimicrobial and anticancer properties. Market trends indicate growing demand in pharmaceutical and biotech sectors. Emerging studies focus on its potential in drug development and therapeutic applications.

Waste should be collected in proper containers and stored until professional disposal. Incineration or professional waste disposal facilities are recommended. Environmental protection measures include neutralizing the waste to minimize environmental impact and ensuring compliance with local and international regulations on hazardous waste management.